Proof-of-concept Clinical Trial: Prevent Cognitive Decline in GBA-Associated Parkinson's Disease

被引：0
|
作者：
Brockmann, K.
Corvol, J. C.
DiFonzo, A.
Durrleman, S.
Gasser, T.
Hu, M.
Krueger, R.
Liepelt-Scarfone, I.
Matarazzo, M.
Pilotto, A.
Simuni, T.
Svenningsson, P.
Weintraub, D.
Pagano, G.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
32
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [31] Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease
    Emelyanov, A. K.
    Baydakova, G. V.
    Andoskin, P. A.
    Nikolaev, M. A.
    Senkevich, K. A.
    Milyukhina, I. V.
    Yakimovskii, A. F.
    Timofeeva, A. A.
    Fedotova, E. Y.
    Nuzhnyi, E. P.
    Illarioshkin, S. N.
    Zakharova, E. Y.
    Pchelina, S. N.
    MOVEMENT DISORDERS, 2016, 31 : S214 - S215
  • [32] Ambroxol treatment of primary macrophages derived from patients with GBA-associated Parkinson's disease
    Kopytova, A.
    Nikolaev, M.
    Senkevich, K.
    Baydakova, G.
    Miliukhina, I.
    Zakharova, E.
    Pchelina, S.
    MOVEMENT DISORDERS, 2019, 34
  • [33] Contribution of the SNCA gene and genes involved in autophagy in the pathogenesis of GBA-associated parkinson's disease
    Basharova, K.
    Bezrukova, A.
    Bogdanova, D.
    Senkevich, K.
    Gracheva, E.
    Miliukhina, I.
    Emelyanov, A.
    Pchelina, S.
    Usenko, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 44 : S11 - S11
  • [34] Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
    Stefanie Lerche
    Milan Zimmermann
    Benjamin Roeben
    Isabel Wurster
    Franca Laura Fries
    Christian Deuschle
    Katharina Waniek
    Ingolf Lachmann
    Meike Jakobi
    Thomas O. Joos
    Thomas Knorpp
    Nicole Schneiderhan-Marra
    Kathrin Brockmann
    npj Parkinson's Disease, 9
  • [35] Cardiovascular autonomic function in GBA-associated Parkinson's disease: a cross-sectional study
    De Santis, T.
    Cocco, A.
    Polverino, P.
    Polvere, V.
    Valente, E. M.
    Albanese, A.
    MOVEMENT DISORDERS, 2023, 38 : S472 - S472
  • [36] Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
    Huh Y.E.
    Park H.
    Chiang M.S.R.
    Tuncali I.
    Liu G.
    Locascio J.J.
    Shirvan J.
    Hutten S.J.
    Rotunno M.S.
    Viel C.
    Shihabuddin L.S.
    Wang B.
    Sardi S.P.
    Scherzer C.R.
    npj Parkinson's Disease, 7 (1)
  • [37] Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
    Lerche, Stefanie
    Zimmermann, Milan
    Roeben, Benjamin
    Wurster, Isabel
    Fries, Franca Laura
    Deuschle, Christian
    Waniek, Katharina
    Lachmann, Ingolf
    Jakobi, Meike
    Joos, Thomas O.
    Knorpp, Thomas
    Schneiderhan-Marra, Nicole
    Brockmann, Kathrin
    NPJ PARKINSONS DISEASE, 2023, 9 (01)
  • [38] Proof-of-concept clinical trial on the use of oral ridaforolimus, an investigational mTOR inhibitor, for enhanced autophagy in Parkinson's disease
    Machado, D. G.
    Jabbari, B.
    MOVEMENT DISORDERS, 2010, 25 (07) : S300 - S300
  • [39] Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial
    Videnovic, Aleksandar
    Amara, Amy W.
    Comella, Cynthia
    Schweitzer, Paula K.
    Emsellem, Helene
    Liu, Kris
    Sterkel, Amanda L.
    Gottwald, Mildred D.
    Steinerman, Joshua R.
    Jochelson, Philip
    Zomorodi, Katie
    Hauser, Robert A.
    MOVEMENT DISORDERS, 2021, 36 (10) : 2408 - 2412
  • [40] The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson disease
    Gan-Or, Z.
    Amshalom, I.
    Bar-Shira, A.
    Gana-Weisz, M.
    Mirelman, A.
    Marder, K.
    Bressman, S.
    Giladi, N.
    Orr-Urtreger, A.
    JOURNAL OF NEUROLOGY, 2015, 262 (11) : 2443 - 2447
12345